Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial‐mesenchymal transition in salivary adenoid cystic carcinoma
Objectives To investigate the role of hypoxia in vasculogenic mimicry (VM) of salivary adenoid cystic carcinoma (SACC) and the underlying mechanism involved. Materials and methods Firstly, wound healing, transwell invasion, immunofluorescence and tube formation assays were performed to measure the e...
Gespeichert in:
Veröffentlicht in: | Cell proliferation 2019-05, Vol.52 (3), p.e12600-n/a |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 3 |
container_start_page | e12600 |
container_title | Cell proliferation |
container_volume | 52 |
creator | Wang, Hao‐fan Wang, Sha‐sha Zheng, Min Dai, Lu‐ling Wang, Ke Gao, Xiao‐lei Cao, Ming‐xin Yu, Xiang‐hua Pang, Xin Zhang, Mei Wu, Jing‐biao Wu, Jia‐shun Yang, Xiao Tang, Ya‐jie Chen, Yu Tang, Ya‐ling Liang, Xin‐hua |
description | Objectives
To investigate the role of hypoxia in vasculogenic mimicry (VM) of salivary adenoid cystic carcinoma (SACC) and the underlying mechanism involved.
Materials and methods
Firstly, wound healing, transwell invasion, immunofluorescence and tube formation assays were performed to measure the effect of hypoxia on migration, invasion, EMT and VM of SACC cells, respectively. Then, immunofluorescence and RT‐PCR were used to detect the effect of hypoxia on VE‐cadherin and VEGFA expression. And pro‐vasculogenic mimicry effect of VEGFA was investigated by confocal laser scanning microscopy and Western blot. Moreover, the levels of E‐cadherin, N‐cadherin, Vimentin, CD44 and ALDH1 were determined by Western blot and immunofluorescence in SACC cells treated by exogenous VEGFA or bevacizumab. Finally, CD31/ PAS staining was performed to observe VM and immunohistochemistry was used to determine the levels of VEGFA and HIF‐1α in 95 SACC patients. The relationships between VM and clinicopathological variables, VEGFA or HIF‐1α level were analysed.
Results
Hypoxia promoted cell migration, invasion, EMT and VM formation, and enhanced VE‐cadherin and VEGFA expression in SACC cells. Further, exogenous VEGFA markedly increased the levels of N‐cadherin, Vimentin, CD44 and ALDH1, and inhibited the expression of E‐cadherin, while the VEGFA inhibitor reversed these changes. In addition, VM channels existed in 25 of 95 SACC samples, and there was a strong positive correlation between VM and clinic stage, distant metastases, VEGFA and HIF‐1α expression.
Conclusions
VEGFA played an important role in hypoxia‐induced VM through regulating EMT and stemness, which may eventually fuel the migration and invasion of SACC. |
doi_str_mv | 10.1111/cpr.12600 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6536414</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2230466011</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4430-e4ddc41e18d968bea7844173eedf15361d4e78decbe4c41a6415fd29d7de45823</originalsourceid><addsrcrecordid>eNp1ks9uEzEQhy1ERUPhwAsgS1zgsK29drybC1IVAa1UqQjB2XLs2cSV_yz2bsreeASeg8fiSXCaUFEkfPHB33z-jWYQekHJKS3nTPfplNaCkEdoRpmYVzVt-WM0IwtBqqap62P0NOcbQiijjXiCjhlZ8DkTdIZ-Xkx9_GYV7lP0cYCMtyrr0cU1BKuxt97qNOEuJq8GGwNeTQdCJQzBxGEDziqH1yneDhvcKT3EhM-xB2NLRVhj6O0B-vX9h4cMQW8mX0qGpEK2d1YbcFbOblX5SxkI0RqspzyUCFolbUP06hk66pTL8Pxwn6Av7999Xl5UV9cfLpfnV5XmnJEKuDGaU6CtWYh2BappOacNAzAd3TVtODStAb0CXjglOJ13pl6YxgCftzU7QW_33n5clS40hBLUyT5ZX-LJqKx8-BLsRq7jVopi55QXweuDIMWvI-RBeps1OKcCxDHLuiasYG2zQ1_9g97EMYXSXqEY4UIQSgv1Zk_pFHNO0N2HoUTuNkCWDZB3G1DYl3-nvyf_jLwAZ3vg1jqY_m-Sy4-f9srfNZHCKg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2230466011</pqid></control><display><type>article</type><title>Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial‐mesenchymal transition in salivary adenoid cystic carcinoma</title><source>PubMed (Medline)</source><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>MEDLINE</source><source>Wiley Online Library All Journals</source><source>Directory of Open Access Journals</source><creator>Wang, Hao‐fan ; Wang, Sha‐sha ; Zheng, Min ; Dai, Lu‐ling ; Wang, Ke ; Gao, Xiao‐lei ; Cao, Ming‐xin ; Yu, Xiang‐hua ; Pang, Xin ; Zhang, Mei ; Wu, Jing‐biao ; Wu, Jia‐shun ; Yang, Xiao ; Tang, Ya‐jie ; Chen, Yu ; Tang, Ya‐ling ; Liang, Xin‐hua</creator><creatorcontrib>Wang, Hao‐fan ; Wang, Sha‐sha ; Zheng, Min ; Dai, Lu‐ling ; Wang, Ke ; Gao, Xiao‐lei ; Cao, Ming‐xin ; Yu, Xiang‐hua ; Pang, Xin ; Zhang, Mei ; Wu, Jing‐biao ; Wu, Jia‐shun ; Yang, Xiao ; Tang, Ya‐jie ; Chen, Yu ; Tang, Ya‐ling ; Liang, Xin‐hua</creatorcontrib><description>Objectives
To investigate the role of hypoxia in vasculogenic mimicry (VM) of salivary adenoid cystic carcinoma (SACC) and the underlying mechanism involved.
Materials and methods
Firstly, wound healing, transwell invasion, immunofluorescence and tube formation assays were performed to measure the effect of hypoxia on migration, invasion, EMT and VM of SACC cells, respectively. Then, immunofluorescence and RT‐PCR were used to detect the effect of hypoxia on VE‐cadherin and VEGFA expression. And pro‐vasculogenic mimicry effect of VEGFA was investigated by confocal laser scanning microscopy and Western blot. Moreover, the levels of E‐cadherin, N‐cadherin, Vimentin, CD44 and ALDH1 were determined by Western blot and immunofluorescence in SACC cells treated by exogenous VEGFA or bevacizumab. Finally, CD31/ PAS staining was performed to observe VM and immunohistochemistry was used to determine the levels of VEGFA and HIF‐1α in 95 SACC patients. The relationships between VM and clinicopathological variables, VEGFA or HIF‐1α level were analysed.
Results
Hypoxia promoted cell migration, invasion, EMT and VM formation, and enhanced VE‐cadherin and VEGFA expression in SACC cells. Further, exogenous VEGFA markedly increased the levels of N‐cadherin, Vimentin, CD44 and ALDH1, and inhibited the expression of E‐cadherin, while the VEGFA inhibitor reversed these changes. In addition, VM channels existed in 25 of 95 SACC samples, and there was a strong positive correlation between VM and clinic stage, distant metastases, VEGFA and HIF‐1α expression.
Conclusions
VEGFA played an important role in hypoxia‐induced VM through regulating EMT and stemness, which may eventually fuel the migration and invasion of SACC.</description><identifier>ISSN: 0960-7722</identifier><identifier>EISSN: 1365-2184</identifier><identifier>DOI: 10.1111/cpr.12600</identifier><identifier>PMID: 30945361</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>Adenoid ; Adult ; Angiogenesis Inhibitors - pharmacology ; Antigens, CD - genetics ; Antigens, CD - metabolism ; Bevacizumab ; Bevacizumab - pharmacology ; Cadherins - genetics ; Cadherins - metabolism ; Carcinoma, Adenoid Cystic - blood supply ; Carcinoma, Adenoid Cystic - metabolism ; Carcinoma, Adenoid Cystic - pathology ; CD44 antigen ; Cell adhesion & migration ; Cell Line, Tumor ; Cell migration ; Cell Movement ; Confocal microscopy ; Epithelial-Mesenchymal Transition - genetics ; Epithelial-Mesenchymal Transition - physiology ; epithelial‐mesenchymal transition ; Female ; Gene Expression Regulation, Neoplastic ; Growth factors ; Humans ; Hypoxia ; Hypoxia-Inducible Factor 1, alpha Subunit - metabolism ; Immunofluorescence ; Immunohistochemistry ; Levels ; Male ; Mesenchyme ; Metastases ; Microscopy ; Middle Aged ; Mimicry ; Monoclonal antibodies ; Neoplasm Invasiveness ; Neovascularization, Pathologic ; Original ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; salivary adenoid cystic carcinoma ; Salivary Gland Neoplasms - blood supply ; Salivary Gland Neoplasms - metabolism ; Salivary Gland Neoplasms - pathology ; Scanning microscopy ; Tumor Hypoxia - physiology ; Vascular endothelial growth factor ; vascular endothelial growth factor A ; Vascular Endothelial Growth Factor A - antagonists & inhibitors ; Vascular Endothelial Growth Factor A - genetics ; Vascular Endothelial Growth Factor A - metabolism ; vasculogenic mimicry ; Vimentin ; Wound healing</subject><ispartof>Cell proliferation, 2019-05, Vol.52 (3), p.e12600-n/a</ispartof><rights>2019 The Authors. Published by John Wiley & Sons Ltd</rights><rights>2019 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd.</rights><rights>2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4430-e4ddc41e18d968bea7844173eedf15361d4e78decbe4c41a6415fd29d7de45823</citedby><cites>FETCH-LOGICAL-c4430-e4ddc41e18d968bea7844173eedf15361d4e78decbe4c41a6415fd29d7de45823</cites><orcidid>0000-0002-1181-1672</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536414/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536414/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30945361$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Hao‐fan</creatorcontrib><creatorcontrib>Wang, Sha‐sha</creatorcontrib><creatorcontrib>Zheng, Min</creatorcontrib><creatorcontrib>Dai, Lu‐ling</creatorcontrib><creatorcontrib>Wang, Ke</creatorcontrib><creatorcontrib>Gao, Xiao‐lei</creatorcontrib><creatorcontrib>Cao, Ming‐xin</creatorcontrib><creatorcontrib>Yu, Xiang‐hua</creatorcontrib><creatorcontrib>Pang, Xin</creatorcontrib><creatorcontrib>Zhang, Mei</creatorcontrib><creatorcontrib>Wu, Jing‐biao</creatorcontrib><creatorcontrib>Wu, Jia‐shun</creatorcontrib><creatorcontrib>Yang, Xiao</creatorcontrib><creatorcontrib>Tang, Ya‐jie</creatorcontrib><creatorcontrib>Chen, Yu</creatorcontrib><creatorcontrib>Tang, Ya‐ling</creatorcontrib><creatorcontrib>Liang, Xin‐hua</creatorcontrib><title>Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial‐mesenchymal transition in salivary adenoid cystic carcinoma</title><title>Cell proliferation</title><addtitle>Cell Prolif</addtitle><description>Objectives
To investigate the role of hypoxia in vasculogenic mimicry (VM) of salivary adenoid cystic carcinoma (SACC) and the underlying mechanism involved.
Materials and methods
Firstly, wound healing, transwell invasion, immunofluorescence and tube formation assays were performed to measure the effect of hypoxia on migration, invasion, EMT and VM of SACC cells, respectively. Then, immunofluorescence and RT‐PCR were used to detect the effect of hypoxia on VE‐cadherin and VEGFA expression. And pro‐vasculogenic mimicry effect of VEGFA was investigated by confocal laser scanning microscopy and Western blot. Moreover, the levels of E‐cadherin, N‐cadherin, Vimentin, CD44 and ALDH1 were determined by Western blot and immunofluorescence in SACC cells treated by exogenous VEGFA or bevacizumab. Finally, CD31/ PAS staining was performed to observe VM and immunohistochemistry was used to determine the levels of VEGFA and HIF‐1α in 95 SACC patients. The relationships between VM and clinicopathological variables, VEGFA or HIF‐1α level were analysed.
Results
Hypoxia promoted cell migration, invasion, EMT and VM formation, and enhanced VE‐cadherin and VEGFA expression in SACC cells. Further, exogenous VEGFA markedly increased the levels of N‐cadherin, Vimentin, CD44 and ALDH1, and inhibited the expression of E‐cadherin, while the VEGFA inhibitor reversed these changes. In addition, VM channels existed in 25 of 95 SACC samples, and there was a strong positive correlation between VM and clinic stage, distant metastases, VEGFA and HIF‐1α expression.
Conclusions
VEGFA played an important role in hypoxia‐induced VM through regulating EMT and stemness, which may eventually fuel the migration and invasion of SACC.</description><subject>Adenoid</subject><subject>Adult</subject><subject>Angiogenesis Inhibitors - pharmacology</subject><subject>Antigens, CD - genetics</subject><subject>Antigens, CD - metabolism</subject><subject>Bevacizumab</subject><subject>Bevacizumab - pharmacology</subject><subject>Cadherins - genetics</subject><subject>Cadherins - metabolism</subject><subject>Carcinoma, Adenoid Cystic - blood supply</subject><subject>Carcinoma, Adenoid Cystic - metabolism</subject><subject>Carcinoma, Adenoid Cystic - pathology</subject><subject>CD44 antigen</subject><subject>Cell adhesion & migration</subject><subject>Cell Line, Tumor</subject><subject>Cell migration</subject><subject>Cell Movement</subject><subject>Confocal microscopy</subject><subject>Epithelial-Mesenchymal Transition - genetics</subject><subject>Epithelial-Mesenchymal Transition - physiology</subject><subject>epithelial‐mesenchymal transition</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Growth factors</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</subject><subject>Immunofluorescence</subject><subject>Immunohistochemistry</subject><subject>Levels</subject><subject>Male</subject><subject>Mesenchyme</subject><subject>Metastases</subject><subject>Microscopy</subject><subject>Middle Aged</subject><subject>Mimicry</subject><subject>Monoclonal antibodies</subject><subject>Neoplasm Invasiveness</subject><subject>Neovascularization, Pathologic</subject><subject>Original</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>salivary adenoid cystic carcinoma</subject><subject>Salivary Gland Neoplasms - blood supply</subject><subject>Salivary Gland Neoplasms - metabolism</subject><subject>Salivary Gland Neoplasms - pathology</subject><subject>Scanning microscopy</subject><subject>Tumor Hypoxia - physiology</subject><subject>Vascular endothelial growth factor</subject><subject>vascular endothelial growth factor A</subject><subject>Vascular Endothelial Growth Factor A - antagonists & inhibitors</subject><subject>Vascular Endothelial Growth Factor A - genetics</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><subject>vasculogenic mimicry</subject><subject>Vimentin</subject><subject>Wound healing</subject><issn>0960-7722</issn><issn>1365-2184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1ks9uEzEQhy1ERUPhwAsgS1zgsK29drybC1IVAa1UqQjB2XLs2cSV_yz2bsreeASeg8fiSXCaUFEkfPHB33z-jWYQekHJKS3nTPfplNaCkEdoRpmYVzVt-WM0IwtBqqap62P0NOcbQiijjXiCjhlZ8DkTdIZ-Xkx9_GYV7lP0cYCMtyrr0cU1BKuxt97qNOEuJq8GGwNeTQdCJQzBxGEDziqH1yneDhvcKT3EhM-xB2NLRVhj6O0B-vX9h4cMQW8mX0qGpEK2d1YbcFbOblX5SxkI0RqspzyUCFolbUP06hk66pTL8Pxwn6Av7999Xl5UV9cfLpfnV5XmnJEKuDGaU6CtWYh2BappOacNAzAd3TVtODStAb0CXjglOJ13pl6YxgCftzU7QW_33n5clS40hBLUyT5ZX-LJqKx8-BLsRq7jVopi55QXweuDIMWvI-RBeps1OKcCxDHLuiasYG2zQ1_9g97EMYXSXqEY4UIQSgv1Zk_pFHNO0N2HoUTuNkCWDZB3G1DYl3-nvyf_jLwAZ3vg1jqY_m-Sy4-f9srfNZHCKg</recordid><startdate>201905</startdate><enddate>201905</enddate><creator>Wang, Hao‐fan</creator><creator>Wang, Sha‐sha</creator><creator>Zheng, Min</creator><creator>Dai, Lu‐ling</creator><creator>Wang, Ke</creator><creator>Gao, Xiao‐lei</creator><creator>Cao, Ming‐xin</creator><creator>Yu, Xiang‐hua</creator><creator>Pang, Xin</creator><creator>Zhang, Mei</creator><creator>Wu, Jing‐biao</creator><creator>Wu, Jia‐shun</creator><creator>Yang, Xiao</creator><creator>Tang, Ya‐jie</creator><creator>Chen, Yu</creator><creator>Tang, Ya‐ling</creator><creator>Liang, Xin‐hua</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1181-1672</orcidid></search><sort><creationdate>201905</creationdate><title>Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial‐mesenchymal transition in salivary adenoid cystic carcinoma</title><author>Wang, Hao‐fan ; Wang, Sha‐sha ; Zheng, Min ; Dai, Lu‐ling ; Wang, Ke ; Gao, Xiao‐lei ; Cao, Ming‐xin ; Yu, Xiang‐hua ; Pang, Xin ; Zhang, Mei ; Wu, Jing‐biao ; Wu, Jia‐shun ; Yang, Xiao ; Tang, Ya‐jie ; Chen, Yu ; Tang, Ya‐ling ; Liang, Xin‐hua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4430-e4ddc41e18d968bea7844173eedf15361d4e78decbe4c41a6415fd29d7de45823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adenoid</topic><topic>Adult</topic><topic>Angiogenesis Inhibitors - pharmacology</topic><topic>Antigens, CD - genetics</topic><topic>Antigens, CD - metabolism</topic><topic>Bevacizumab</topic><topic>Bevacizumab - pharmacology</topic><topic>Cadherins - genetics</topic><topic>Cadherins - metabolism</topic><topic>Carcinoma, Adenoid Cystic - blood supply</topic><topic>Carcinoma, Adenoid Cystic - metabolism</topic><topic>Carcinoma, Adenoid Cystic - pathology</topic><topic>CD44 antigen</topic><topic>Cell adhesion & migration</topic><topic>Cell Line, Tumor</topic><topic>Cell migration</topic><topic>Cell Movement</topic><topic>Confocal microscopy</topic><topic>Epithelial-Mesenchymal Transition - genetics</topic><topic>Epithelial-Mesenchymal Transition - physiology</topic><topic>epithelial‐mesenchymal transition</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Growth factors</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</topic><topic>Immunofluorescence</topic><topic>Immunohistochemistry</topic><topic>Levels</topic><topic>Male</topic><topic>Mesenchyme</topic><topic>Metastases</topic><topic>Microscopy</topic><topic>Middle Aged</topic><topic>Mimicry</topic><topic>Monoclonal antibodies</topic><topic>Neoplasm Invasiveness</topic><topic>Neovascularization, Pathologic</topic><topic>Original</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>salivary adenoid cystic carcinoma</topic><topic>Salivary Gland Neoplasms - blood supply</topic><topic>Salivary Gland Neoplasms - metabolism</topic><topic>Salivary Gland Neoplasms - pathology</topic><topic>Scanning microscopy</topic><topic>Tumor Hypoxia - physiology</topic><topic>Vascular endothelial growth factor</topic><topic>vascular endothelial growth factor A</topic><topic>Vascular Endothelial Growth Factor A - antagonists & inhibitors</topic><topic>Vascular Endothelial Growth Factor A - genetics</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><topic>vasculogenic mimicry</topic><topic>Vimentin</topic><topic>Wound healing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Hao‐fan</creatorcontrib><creatorcontrib>Wang, Sha‐sha</creatorcontrib><creatorcontrib>Zheng, Min</creatorcontrib><creatorcontrib>Dai, Lu‐ling</creatorcontrib><creatorcontrib>Wang, Ke</creatorcontrib><creatorcontrib>Gao, Xiao‐lei</creatorcontrib><creatorcontrib>Cao, Ming‐xin</creatorcontrib><creatorcontrib>Yu, Xiang‐hua</creatorcontrib><creatorcontrib>Pang, Xin</creatorcontrib><creatorcontrib>Zhang, Mei</creatorcontrib><creatorcontrib>Wu, Jing‐biao</creatorcontrib><creatorcontrib>Wu, Jia‐shun</creatorcontrib><creatorcontrib>Yang, Xiao</creatorcontrib><creatorcontrib>Tang, Ya‐jie</creatorcontrib><creatorcontrib>Chen, Yu</creatorcontrib><creatorcontrib>Tang, Ya‐ling</creatorcontrib><creatorcontrib>Liang, Xin‐hua</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cell proliferation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Hao‐fan</au><au>Wang, Sha‐sha</au><au>Zheng, Min</au><au>Dai, Lu‐ling</au><au>Wang, Ke</au><au>Gao, Xiao‐lei</au><au>Cao, Ming‐xin</au><au>Yu, Xiang‐hua</au><au>Pang, Xin</au><au>Zhang, Mei</au><au>Wu, Jing‐biao</au><au>Wu, Jia‐shun</au><au>Yang, Xiao</au><au>Tang, Ya‐jie</au><au>Chen, Yu</au><au>Tang, Ya‐ling</au><au>Liang, Xin‐hua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial‐mesenchymal transition in salivary adenoid cystic carcinoma</atitle><jtitle>Cell proliferation</jtitle><addtitle>Cell Prolif</addtitle><date>2019-05</date><risdate>2019</risdate><volume>52</volume><issue>3</issue><spage>e12600</spage><epage>n/a</epage><pages>e12600-n/a</pages><issn>0960-7722</issn><eissn>1365-2184</eissn><abstract>Objectives
To investigate the role of hypoxia in vasculogenic mimicry (VM) of salivary adenoid cystic carcinoma (SACC) and the underlying mechanism involved.
Materials and methods
Firstly, wound healing, transwell invasion, immunofluorescence and tube formation assays were performed to measure the effect of hypoxia on migration, invasion, EMT and VM of SACC cells, respectively. Then, immunofluorescence and RT‐PCR were used to detect the effect of hypoxia on VE‐cadherin and VEGFA expression. And pro‐vasculogenic mimicry effect of VEGFA was investigated by confocal laser scanning microscopy and Western blot. Moreover, the levels of E‐cadherin, N‐cadherin, Vimentin, CD44 and ALDH1 were determined by Western blot and immunofluorescence in SACC cells treated by exogenous VEGFA or bevacizumab. Finally, CD31/ PAS staining was performed to observe VM and immunohistochemistry was used to determine the levels of VEGFA and HIF‐1α in 95 SACC patients. The relationships between VM and clinicopathological variables, VEGFA or HIF‐1α level were analysed.
Results
Hypoxia promoted cell migration, invasion, EMT and VM formation, and enhanced VE‐cadherin and VEGFA expression in SACC cells. Further, exogenous VEGFA markedly increased the levels of N‐cadherin, Vimentin, CD44 and ALDH1, and inhibited the expression of E‐cadherin, while the VEGFA inhibitor reversed these changes. In addition, VM channels existed in 25 of 95 SACC samples, and there was a strong positive correlation between VM and clinic stage, distant metastases, VEGFA and HIF‐1α expression.
Conclusions
VEGFA played an important role in hypoxia‐induced VM through regulating EMT and stemness, which may eventually fuel the migration and invasion of SACC.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>30945361</pmid><doi>10.1111/cpr.12600</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-1181-1672</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-7722 |
ispartof | Cell proliferation, 2019-05, Vol.52 (3), p.e12600-n/a |
issn | 0960-7722 1365-2184 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6536414 |
source | PubMed (Medline); Open Access: Wiley-Blackwell Open Access Journals; MEDLINE; Wiley Online Library All Journals; Directory of Open Access Journals |
subjects | Adenoid Adult Angiogenesis Inhibitors - pharmacology Antigens, CD - genetics Antigens, CD - metabolism Bevacizumab Bevacizumab - pharmacology Cadherins - genetics Cadherins - metabolism Carcinoma, Adenoid Cystic - blood supply Carcinoma, Adenoid Cystic - metabolism Carcinoma, Adenoid Cystic - pathology CD44 antigen Cell adhesion & migration Cell Line, Tumor Cell migration Cell Movement Confocal microscopy Epithelial-Mesenchymal Transition - genetics Epithelial-Mesenchymal Transition - physiology epithelial‐mesenchymal transition Female Gene Expression Regulation, Neoplastic Growth factors Humans Hypoxia Hypoxia-Inducible Factor 1, alpha Subunit - metabolism Immunofluorescence Immunohistochemistry Levels Male Mesenchyme Metastases Microscopy Middle Aged Mimicry Monoclonal antibodies Neoplasm Invasiveness Neovascularization, Pathologic Original RNA, Messenger - genetics RNA, Messenger - metabolism salivary adenoid cystic carcinoma Salivary Gland Neoplasms - blood supply Salivary Gland Neoplasms - metabolism Salivary Gland Neoplasms - pathology Scanning microscopy Tumor Hypoxia - physiology Vascular endothelial growth factor vascular endothelial growth factor A Vascular Endothelial Growth Factor A - antagonists & inhibitors Vascular Endothelial Growth Factor A - genetics Vascular Endothelial Growth Factor A - metabolism vasculogenic mimicry Vimentin Wound healing |
title | Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial‐mesenchymal transition in salivary adenoid cystic carcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T16%3A51%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypoxia%20promotes%20vasculogenic%20mimicry%20formation%20by%20vascular%20endothelial%20growth%20factor%20A%20mediating%20epithelial%E2%80%90mesenchymal%20transition%20in%20salivary%20adenoid%20cystic%20carcinoma&rft.jtitle=Cell%20proliferation&rft.au=Wang,%20Hao%E2%80%90fan&rft.date=2019-05&rft.volume=52&rft.issue=3&rft.spage=e12600&rft.epage=n/a&rft.pages=e12600-n/a&rft.issn=0960-7722&rft.eissn=1365-2184&rft_id=info:doi/10.1111/cpr.12600&rft_dat=%3Cproquest_pubme%3E2230466011%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2230466011&rft_id=info:pmid/30945361&rfr_iscdi=true |